Moderna (MRNA)
Latest
-
Stock Market Today: Stocks End Mixed After FOMC Minutes
The minutes from the December Fed meeting signaled central bankers' uncertainty over potential Trump administration policies.
By Karee Venema Published
-
Moderna Stock Is Volatile Amid Bird Flu Developments
Moderna stock has been volatile this week as the first death in the U.S. connected to bird flu was reported. Here's what you need to know.
By Joey Solitro Published
-
Stock Market Today: Stocks Are Mixed Ahead of the Fed
Two of the three main equity indexes closed higher on the first day of the final Fed Week of 2024.
By David Dittman Published
-
Stock Market Today: Stocks Rise in Choppy Day for Markets
Moderna was the worst S&P 500 stock today after the vaccine maker slashed its R&D budget.
By Karee Venema Published
-
Moderna Stock Plunges as Vaccine Maker Slashes R&D Budget: What to Know
Moderna stock is plunging Thursday after the COVID-19 vaccine maker announced plans to drastically cut its R&D spending to focus on new product approvals.
By Joey Solitro Published
-
Should You Invest In IPOs? It's Still A Risky Prospect
Investing in IPOs may sound exciting, but it's often better to wait for newly public stocks to mature before buying.
By Kim Clark Published
-
Stock Market Today: Stocks Slide as Regional Bank Rout Worsens
The major market indexes closed lower Thursday as chaos in the banking industry continued.
By Karee Venema Published
-
Moderna Stock Pops on Surprise Earnings Beat
An unexpected profit and promising news on a deal with the EU boosted Moderna stock.
By Dan Burrows Published
-
Stock Market Today (9/19/22): Stocks Score a Hard-Fought Win to Start the Week
Stock Market Today Price action will likely stay choppy ahead of Wednesday's Fed decision.
By Karee Venema Published
Stock Market Today